| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Nov―07 |
Neuropsychiatric Manifestations of COVID-19 Disease and Post Covid Syndrome: The Role of N Acetyl-cysteine and Acetyl-L-carnitine |
Tommaso Barlattani, Giuseppe Celenza, Alessandro Cavatassi, Franco Minutillo, Valentina Socci, Carolina Pinci, et al. (+2) Riccardo Santini, Francesca Pacitti |
| 2 |
[GO] |
2023―Okt―09 |
Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period |
Wesley Dawison de Lima, Michael Douglas da Silva, Eurico de Souza Costa, Francisco Irochima Pinheiro, Eduardo Pereira de Azevedo, Ricardo Ney Cobucci, et al. (+2) José Rodolfo Lopes de Paiva Cavalcanti, Fausto Pierdoná Guzen |
| 3 |
[GO] |
2023―Jul―30 |
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19 |
|
| 4 |
[GO] |
2023―Jun―16 |
Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19 |
Cindy Bandala, Eleazar Lara-Padilla, Noemí Cárdenas-Rodríguez, Samuel Reyes-Long, Alfredo Cortés-Algara, Itzel Jatziri Contreras-García, et al. (+5) Teresita Rocío Cruz-Hernández, Alfonso Alfaro-Rodriguez, José Luis Cortes-Altamirano, Martín Perez-Santos, Maricruz Anaya-Ruiz |
| 5 |
[GO] |
2022―Dez―07 |
Emerging Evidence for Neuropsycho-Consequences of COVID-19 |
Jingwen Li |
| 6 |
[GO] |
2022―Jul―17 |
Emerging Evidence for Neuropsycho-Consequences of COVID-19 |
Li, JW |
| 7 |
[GO] |
2022―Mrz―11 |
Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19-related trauma |
Sergio De Filippis, Ginevra Lombardozzi, Marta Matrone, Emanuela Amici, Giada Trovini, Filippo Perrini, et al. (+3) Alessandro Di Giovanni, Valeria Giovanetti, Georgios D. Kotzalidis |
| 8 |
[GO] |
2021―Dez―24 |
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19 |
George B. Stefano, Pascal Büttiker, Simon Weissenberger, Radek Ptacek, Fuzhou Wang, Tobias Esch, et al. (+2) Thomas V. Bilfinger, Richard M. Kream |
| 9 |
[GO] |
2021―Jul―30 |
Fluvoxamine and amantadine: central nervous system acting drugs repositioned for COVID-19 as early intervention |
Konrad Rejdak, Paweł Grieb |
| 10 |
[GO] |
2021―Jun―30 |
The impact of SARS-Cov-2 on the Nervous system and Mental Health |
Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Mikhail Arisov, Julia Fedotova, Lucia Gozzo, et al. (+5) Filippo Drago, Weihong Lu, Alexey Sarapultsev, Vadim Tceilikman, Denis Baranenko |
| 11 |
[GO] |
2021―Apr―08 |
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System |
Giselle Pentón-Rol, Javier Marín-Prida, Mark F. McCarty |
| 12 |
[GO] |
2021―Mrz―31 |
Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint |
Marika Alborghetti, Gianmarco Bellucci, Antonietta Gentile, Chiara Calderoni, Ferdinando Nicoletti, Ruggero Capra, et al. (+2) Marco Salvetti, Diego Centonze |
| 13 |
[GO] |
2021―Mrz―16 |
The Stress of the COVID-19 Pandemic: Beyond the Data |
Samina Salim |
| 14 |
[GO] |
2021―Jan―14 |
Crosstalk Between Covid-19 And Associated Neurological Disorders: A Review |
Subham Das, Alex Joseph |
| 15 |
[GO] |
2021―Jan―14 |
PTSD in the COVID-19 Era |
Farah Chamaa, Hisham F. Bahmad, Batoul Darwish, Jana M. Kobeissi, Malak Hoballah, Sibell Bou Nassif, et al. (+4) Yara Ghandour, Jean-Paul Saliba, Nada Lawand, Wassim Abou-Kheir |
| 16 |
[GO] |
2020―Mai―07 |
Emerging evidence for neuropsycho-consequences of COVID-19 |
Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Fang Fang, Xuefei Lv, et al. (+6) Dandan Zhang, Yu Sun, Na Li, Shaoping Hu, Zhicheng Lin, Nian Xiong |
|
